Duality Advisers’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-39,977
| Closed | -$1.87M | – | 423 |
|
|
2024
Q1 | $1.87M | Buy |
39,977
+606
| +2% | +$28.3K | 0.18% | 197 |
|
|
2023
Q4 | $1.88M | Buy |
39,371
+12,333
| +46% | +$590K | 0.2% | 183 |
|
|
2023
Q3 | $964K | Buy |
27,038
+12,715
| +89% | +$453K | 0.12% | 302 |
|
|
2023
Q2 | $661K | Buy |
+14,323
| New | +$661K | 0.08% | 349 |
|
|
2022
Q4 | – | Sell |
-47,879
| Closed | -$1.98M | – | 742 |
|
|
2022
Q3 | $1.98M | Buy |
+47,879
| New | +$1.98M | 0.22% | 180 |
|